LP(A) LIPOPROTEIN, IGG, IGA AND IGM ANTIBODIES TO CHLAMYDIA-PNEUMONIAE AND HLA CLASS-II GENOTYPE IN EARLY CORONARY-ARTERY DISEASE

被引:101
作者
DAHLEN, GH
BOMAN, J
BIRGANDER, LS
LINDBLOM, B
机构
[1] UMEA UNIV HOSP,DEPT CLIN VIROL,S-90185 UMEA,SWEDEN
[2] UMEA UNIV HOSP,DEPT MED,S-90185 UMEA,SWEDEN
[3] LINKOPING UNIV HOSP,STATE INST FORENS SEROL,S-58185 LINKOPING,SWEDEN
关键词
LP(A) LIPOPROTEIN; CHLAMYDIA PNEUMONIAE; HLA ANTIGENS; CYTOKINES; CORONARY HEART DISEASE; AUTOIMMUNE DISORDERS;
D O I
10.1016/0021-9150(94)05480-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The associations previously found between lipoprotein(a) (Lp(a)) levels and atherosclerotic disorders, diabetes, rheumatoid arthritis and renal diseases suggest that Lp(a) may be involved in autoimmune reactions. The relation found between Lp(a) levels and the HLA class II genotype in males with early coronary artery disease (CAD) further support that assumption. It was suggested that an autoimmune process, perhaps triggered by a concomitant intracellular infection may occur especially in patients with inherited high Lp(a) levels in combination with certain inherited HLA class II genotypes. In this study a Chlamydia pneumoniae IgG titer greater than or equal to 32 was significantly more common (P = 0.036) in CAD patients than in matched controls. This is in agreement with previous reports by other investigators. In addition, an IgG titer greater than or equal to 256 in combination with an Lp(a) level greater than or equal to 120 mg/l was found to occur significantly more often (P = 0.011) in male patients than in male controls. Certain HLA class II DR genotypes in combination with high Lp(a) levels and C. pneumoniae titers occurred more frequently in both male and female patients than in controls. Some combinations were very common in male patients, and the difference in comparison with male controls was highly significant.
引用
收藏
页码:165 / 174
页数:10
相关论文
共 27 条
  • [1] SEQUENCE POLYMORPHISMS IN THE APOLIPOPROTEIN(A) GENE - EVIDENCE FOR DISSOCIATION BETWEEN APOLIPOPROTEIN(A) SIZE AND PLASMA LIPOPROTEIN(A) LEVELS
    COHEN, JC
    CHIESA, G
    HOBBS, HH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1630 - 1636
  • [2] DAHLEN G, 1990, FROM PHENOTYPE TO GENE IN COMMON DISORDERS, P163
  • [3] DAHLEN G, 1979, CLIN GENET, V16, P418
  • [4] Dahlen G H, 1988, Prog Clin Biol Res, V255, P27
  • [5] LP(A) LIPOPROTEIN IN CARDIOVASCULAR-DISEASE
    DAHLEN, GH
    [J]. ATHEROSCLEROSIS, 1994, 108 (02) : 111 - 126
  • [6] DAHLEN GH, 1994, CLIN GENET, V46, P46
  • [7] ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY
    DAHLEN, GH
    GUYTON, JR
    ATTAR, M
    FARMER, JA
    KAUTZ, JA
    GOTTO, AM
    [J]. CIRCULATION, 1986, 74 (04) : 758 - 765
  • [8] LIPOPROTEIN(A), ATHEROSCLEROSIS AND THROMBOSIS
    DAHLEN, GH
    [J]. PROGRESS IN LIPID RESEARCH, 1991, 30 (2-3) : 189 - 194
  • [9] INDICATIONS OF AN AUTOIMMUNE COMPONENT IN LP(A) ASSOCIATED DISORDERS
    DAHLEN, GH
    [J]. EUROPEAN JOURNAL OF IMMUNOGENETICS, 1994, 21 (05): : 301 - 312
  • [10] DAHLEN GH, 1975, ACTA MED SCAND, P570